Karla Therapeutics

Karla Therapeutics aims to treat mood disorders with antibodies that neutralize a newly discovered circulating protein secreted by T-Cells (Imood). Data in mice from this team demonstrates that increased Imood expression leads to anxiety-like behaviours, and blocking Imood expression regresses anxiety-like behaviours,

Operating in neuro, Karla Therapeutics operates.

Profile

Karla Therapeutics aims to treat mood disorders with antibodies that neutralize a newly discovered circulating protein secreted by T-Cells (Imood). Data in mice from this team demonstrates that increased Imood expression leads to anxiety-like behaviours, and blocking Imood expression regresses anxiety-like behaviours, while patients with psychiatric disorders exhibit increased levels of Imood. Approximately one in […]

Karla Therapeutics is positioned in neuro, a segment that rewards a clear, focused offering.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.karla-tx.com